Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

Catherine Liu(University of California, San Francisco), Arnold S. Bayer(UCLA Medical Center), Sara E. Cosgrove(Johns Hopkins University), Robert S. Daum(University of Chicago), Scott K. Fridkin(University of California, San Francisco), Rachel Gorwitz(Centers for Disease Control and Prevention), Sheldon L. Kaplan(Baylor College of Medicine), Adolf W. Karchmer(Beth Israel Deaconess Medical Center), Donald P. Levine(Wayne State University), Barbara E. Murray(Texas Center for Infectious Disease), Michael J. Rybak(Detroit Receiving Hospital), David A. Talan(Olive View-UCLA Medical Center), Henry F. Chambers(San Francisco General Hospital)
Clinical Infectious Diseases
January 10, 2011
10.1093/cid/cir034
Cited by 1,596Open Access
Full Text

Abstract

Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.

Related Papers

No related papers found

Powered by citation graph analysis